Quarterly report pursuant to Section 13 or 15(d)

5. Hybrid Debt Instrument (Details Narrative)

v3.7.0.1
5. Hybrid Debt Instrument (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Hybrid debt instruments outstanding $ 0   $ 0
Loss on issuance of debt hybrid $ 0 $ (1,584,218)  
Pharmsynthez [Member]      
Stock issued for convertible note, shares issued 125,397    
Hybrid Debt Instrument [Member] | Pharmsynthez [Member]      
Stock issued for convertible note, shares issued     1,373,036
Stock issued for convertible note, amount converted     $ 6,500,000
Accrued interest converted     $ 200,000